Genetically Determined Folate Deficiency Is Associated With Abnormal Hepatic Folate Profiles in the Spontaneously Hypertensive Rat by Pravenec, M et al.
 1 
Genetically determined folate deficiency is associated with abnormal hepatic folate 
profiles in the spontaneously hypertensive rat 
 
M. PRAVENEC1, K.-Y. LEUNG2, V. ZÍDEK1, P. MLEJNEK1, M. ŠIMÁKOVÁ1, J. 
ŠILHAVÝ1, V. KOŽICH3, N. D. E. GREENE2 
 
1Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic; 
2Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of 
Child Health, University College London, London, UK; 3Department of Pediatrics and 
Adolescent Medicine, Charles University - 1st Faculty of Medicine and General University 
Hospital in Prague, Prague, Czech Republic 
 
 





Michal Pravenec, Institute of Physiology of the Czech Academy of Sciences, Vídeňská 1083, 
14220 Prague 4, Czech Republic; email: pravenec@biomed.cas.cz 
and 
Nicholas Greene, UCL Great Ormond Street Institute of Child Health, Guilford Street, 





Increased levels of plasma cysteine are associated with obesity and metabolic disturbances. 
Our recent genetic analyses in spontaneously hypertensive rats (SHR) revealed a mutated 
Folr1 (folate receptor 1) as the quantitative trait gene associated with diminished renal Folr1 
expression, lower plasma folate levels, hypercysteinemia, hyperhomocysteinemia and 
metabolic disturbances. To further analyze the effects of the Folr1 gene expression on folate 
metabolism, we used mass spectrometry to quantify folate profiles in the plasma and liver of 
an SHR-1 congenic strain, with wild type Folr1 allele on the SHR genetic background, and 
compared them with the SHR strain. In the plasma, concentration of 5-methyltetrahydrofolate 
(5mTHF) was significantly higher in SHR-1 congenic rats compared to SHR (60±6 vs. 42±2 
nmol/l, P<0.01) and 5mTHF monoglutamate was the predominant form in both strains (>99% 
of total folate). In the liver, SHR-1 congenic rats showed a significantly increased level of 
5mTHF and decreased concentrations of dihydrofolate (DHF), tetrahydrofolate (THF) and 
formyl-THF when compared to the SHR strain. We also analyzed the extent of folate 
glutamylation in the liver. Compared with the SHR strain, congenic wild-type Folr1 rats had 
significantly higher levels of 5mTHF monoglutamate. On the other hand, 5mTHF penta- and 
hexaglutamates were significantly higher in SHR when compared to SHR-1 rats. This inverse 
relationship of rat hepatic folate polyglutamate chain length and folate sufficiency was also 
true for other folate species. These results strongly indicate that the whole body homeostasis 
of folates is substantially impaired in SHR rats compared to the SHR-1 congenic strain and 
might be contributing to the associated metabolic disturbances observed in our previous 
studies. 
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The spontaneously hypertensive rat (SHR) is one of the most widely used animal models of 
increased blood pressure and associated metabolic disturbances. In our previous studies, we 
found that the SHR harbors a 5.7-kb deletion in the promoter region of the Folr1 (folate 
receptor 1) gene on chromosome 1 that is associated with reduced renal expression of the 
gene, decreased renal folate reabsorption and lower circulating folate levels, 
hypercysteinemia, and hyperhomocysteinemia when compared to SHR-1 congenic rats with 
the wild-type Folr1 gene (Pravenec et al., 2016). These disturbances in folate homeostasis in 
SHR are associated with higher body weight because of increased adiposity and with 
increased ectopic fat accumulation in liver and muscle when compared to the SHR-1 congenic 
strain. The increased fat accumulation in the SHR was associated with reduced sensitivity of 
skeletal muscle to insulin action (Pravenec et al., 2016). The mechanisms connecting folate 
deficiency, hypercysteinemia and hyperhomocysteinemia with disturbances of lipid 
metabolism are not fully understood and may include an abnormal methylation status (Obeid 
etal., 2009; Carter et al., 2016). Folates are pteroyl(poly)glutamate derivatives with various 
one-carbon moieties at the pterine ring (Shane, 2010). Humans are unable to synthesize 
folates and depend on their production by plants and to some extent possibly also by the gut 
microbiota. Dietary polyglutamylated folates are deglutamylated in the intestine, absorbed 
predominantly by the proton-coupled folate transporter. Four additional folate transporters 
with different expression pattern in various organs provide multiple routes for interorgan 
transport of folates predominately in the form of monoglutamylated 5-methyl-tetrahydrofolate 
(5mTHF). Both the retention of folates in the cells and their conversion to functional cofactors 
require polyglutamylation (Shane, 2010; Lin et al., 1994). It should be noted that the 
folylpolyglutamates are much more effective substrates for one-carbon transfer reactions than 
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the monoglutamylated folate species (Shane, 2010). A number of enzymes participate in 
intracellular metabolism of one-carbon (C-1) moieties attached to the polyglutamylated 
tetrahydrofolate (THF) residue. These C-1 moieties are used to synthesize vital compounds: 
5mTHF remethylates homocysteine back to methionine and subsequently to S-
adenosylmethionine, 10-formylTHF and 5,10-methyleneTHF are used for synthesis of purines 
and of thymidylate, respectively.  
The mechanisms by which folate deficiency in SHR and in mice deficient in the 
methylenetetrahydrofolate reductase activity elicits disturbed lipid metabolism are only 
partially understood (Christensen et al., 2015; Pravenec et al., 2016. One mechanism may 
result from reduced availability of folate for homocysteine remethylation and deficiency of S-
adenosylmethionine with accumulation of S-adenosylhomocysteine. Deficiency of S-
adenosylmethionine and accumulation of S-adenosylhomocysteine could lead to reduced 
production of phosphatidylcholine which is an essential factor for very low-density 
lipoprotein assembly and transport of triglycerides out of the liver. The attendant disturbances 
in hepatic lipid transport could in turn be contributing to ectopic accumulation of fat in liver. 
In the current study, we measured the relative abundance of folate species in plasma and liver 
and the extent of folate glutamylation in the liver in SHR versus SHR-1 congenic rats to 
analyze how genetically determined folate deficiency affects folate metabolism and whether 
these disturbances may be one of the underlying mechanisms connecting low folate status 
with hepatic steatosis. 
 
Materials and Methods 
 
Animals. SHR/OlaIpcv rats (referred to as the SHR strain) and SHR.BN-D1Rat272/Igf2 
congenic rats (referred to as the SHR-1 congenic strain) (St. Lezin et al., 1997), males at the 
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age of 3 months, N = 6 per group, were housed in an air-conditioned animal facility and 
allowed free access to food (diet 1314, Altromin, Germany) and water. The SHR congenic 
strain was derived by a selective breeding protocol in which a segment of chromosome 1 from 
the normotensive BN/Cr strain was transferred onto the genetic background of the progenitor 
SHR. The coat color (C) and a microsatellite marker within the gene encoding insulin-like 
growth factor 2 (Igf2) were used for selection of heterozygous carriers in each back-cross 
generation. After 10 generations of selective back-crossing to the SHR progenitor strain, the 
differential chromosome segment was fixed using the markers D1Mit3 (a microsatellite 
marker that maps close to C) and Igf2 and maintained in the homozygous state by 
brother×sister mating and selective inbreeding of the offspring. All experiments were 
performed in agreement with the Animal Protection Law of the Czech Republic and were 
approved by the Ethics Committee of the Institute of Physiology of the Czech Academy of 
Sciences, Prague. 
 
Quantification of folate one-carbon metabolism (FOCM) intermediates by mass 
spectrometry. Distribution of differentially substituted folate species and the extent of 
glutamylation in plasma and liver of SHR (n=10) and SHR-1 (n=9) 3-month-old males were 
determined. Analysis of multiple folates was performed by UPLC-MS/MS as described 
previously (Pai et al., 2015; Leung et al., 2017). Folate sample buffer containing 20 mM 
ammonia acetate, 0.1% ascorbic acid, 0.1% citric acid and 100mM DTT at pH7 was added to 
liver tissue or at equal volume to plasma. Liver samples were homogenised by sonication for 
10 seconds using a hand-held sonicator at 60% amplitude. Protein was removed by 
precipitation with addition of 2 sample volumes of acetonitrile and centrifugation for 15 
minutes at 12,000 x g and 4°C. Supernatants were transferred to fresh tubes, lyophilised and 
stored at -80°C prior to analysis. Lyophilised plasma samples were resuspended in 30 µl water 
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(milli-Q) and centrifuged for 5 minutes at 12,000 x g at 4°C. Supernatants were transferred to 
glass sample vials for UPLC-MS/MS analysis. Metabolites were resolved by reversed-phase 
chromatography using an Acquity UPLC BEH C18 column (50 mm x 2.1 mm; 1.7 µm bead 
size (Waters Corporation, UK). Solvents for UPLC were: Buffer A, 5% methanol, 95% Milli-
Q water and 5 mM dimethylhexylamine at pH 8.0; Buffer B, 100% methanol.  The column 
was equilibrated with 95% Buffer A: 5% Buffer B. The sample injection volume was 20 μl. 
The UPLC protocol consisted of 95% Buffer A: 5% Buffer B for 1 min, followed by a 
gradient of 5-60% Buffer B over 9 min and then 100% Buffer B for 6 min before re-
equilibration for 4 min. The metabolites were eluted at a flow rate of 200 nl/min. The UPLC 
was coupled to a XEVO-TQS mass spectrometer (Waters Corporation, UK) operating in 
negative-ion mode using the following settings: capillary 2.5 kV, source temperature 150°C, 
desolvation temperature 600°C, cone gas flow rate 150 L/h and desolvation gas flow rate 
1200 L/h. Folates were measured by multiple reaction monitoring (MRM) with optimised 
cone voltage and collision energy for precursor and product ions as described (Cabreiro et al., 
2013; Leung et al., 2013). The plasma samples were spiked with a known concentration of 
methotrexate (MTX) as internal standard at 0.1 pmol/µl plasma to determine the folate 
concentration in plasma (pmol/µl). For the liver, the folate distribution is calculated as relative 
amount of total folate in the sample and is expressed as percentage of the total folate. Using 
buffer at pH 7, some abiotic conversion of CH2-THF to THF occurs (maximal 20% in a tissue 
matrix) but sensitivity is significantly greater than at pH 10 (which stabilises CH2-THF) (Pai 
et al., 2015). 
 
Statistical analysis. Summary results are expressed as mean  SEM. Individual groups were 
compared by unpaired Student t-test. Normality of distribution was tested by Shapiro-Wilk 





Folate profiling. In the plasma, the concentration of 5-methyltetrahydrofolate (5mTHF) was 
significantly higher in SHR-1 congenic rats compared to SHR rats (60±6 vs. 42±2 nmol/l, 
P<0.01) and 5mTHF monoglutamate was the predominant form in both strains (>99% of total 
folate). The folate profile in the liver also differed between strains (Figure 1). The SHR-1 
congenic rats had significantly increased proportion of 5mTHF and decreased percentages of 
DHF, THF, and formyl-THF when compared to SHR. 5mTHF was the predominant form in 
both strains. Most of the hepatic 5mTHF was in the form of monoglutamate (>99%), and the 
relative proportion of monoglutamated 5mTHF was significantly higher in SHR-1 than SHR 
liver (Figure 1). On the other hand, the relative proportion of 5mTHF penta- and 
hexaglutamates were significantly reduced in SHR-1 compared with SHR rat liver (Figure 2). 
The same was true for other folate species: SHR-1 rats when compared to SHR exhibited 
significantly reduced percentages of pentaglutamyl and/or hexaglutamyl forms of DHF, THF, 
methenyl-THF, and methylene-THF in liver. These results demonstrate that there is an inverse 
relationship of rat liver folate polyglutamate chain length and folate sufficiency.  
 
Discussion 
Folate metabolism plays a fundamental role in key cellular functions including nucleotide 
biosynthesis and methylation. Disturbances in folate homeostasis can be estimated from 
changes of downstream biomarkers such as homocysteine concentration, DNA methylation 
and uracil incorporation. On the other hand, folate profiling could provide direct information 
about the abundance of individual folate metabolites that may reflect disturbances of 
particular steps. In the current study, we analyzed the effect of alteration in total abundance of 
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folates on the folate profile by analysing plasma and liver of SHR rats that have a relative 
folate deficiency (owing to Folr1 mutation) compared to the SHR-1 congenic strain, which 
carries a wild type Folr1 allele (Pravenec et al., 2016). We observed significantly lower 
abundance of plasma and total hepatic 5mTHF in the SHR when compared to congenic SHR-
1 rats. This is consistent with our previous findings that mutation of Folr1 in SHR is 
associated with reduced renal expression of Folr1 mRNA, decreased renal folate reabsorption 
and lower circulating folate levels. Interestingly, although total and monoglutamyl 5mTHF 
was lower in abundance in the liver of SHR rats, the 5mTHF penta- and hexaglutamates were 
significantly higher in the SHR compared with SHR-1 congenic rats. The same trend was 
observed for other folate species, including DHF, THF, methenyl-THF, and methylene-THF 
polyglutamates (Figure 2). We hypothesise that this inverse relationship of rat liver folate 
polyglutamate chain length and folate sufficiency reflects the fact that the synthesis of long-
chain folylpolyglutamates in the liver occurs at a slow rate and is limited by competition with 
the entering pteroylmonoglutamate and shorter-chain folylpolyglutamates, which are 
preferred substrates for folylpolyglutamate synthetase. It has been reported that under folate-
restricted conditions, this competition is decreased (Cassady et al., 1980; Varela-Moreiras et 
al., 1992). Thus the increased relative abundance of folates with more than five glutamate 
residues in tissues from rats subject to folate deficiency is consistent with the possibility that 
these folates undergo slower turnover to allow the addition of extra glutamate residues. 
Accordingly, the increased relative abundance of DHF, THF and formyl-THF in the liver of 
SHR versus SHR-1 congenic rats is due to a higher percentage of penta- and hexaglutamate 
forms while the lower hepatic proportion of 5mTHF monoglutamate in SHR versus SHR-1 
rats is likely due to lower cellular uptake, increased polyglutamylation and apparently reduced 
folate turnover. Lower abundance of 5mTHF has been found to result in decreased 
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contribution of methyl groups to the methylation cycle and predisposition to hepatic steatosis 
(Obeid et al., 2009). 
In conclusion, our results strongly indicate that the whole body homeostasis of folates is 
substantially impaired in the SHR compared with the SHR-1 congenic strain. This may be in 
part responsible for the associated metabolic disturbances, including increased serum levels of 
cysteine and homocysteine, increased adiposity, ectopic fat accumulation in liver and muscle, 
reduced muscle insulin sensitivity, and increased blood pressure that are observed in the SHR 
strain (Pravenec et al., 2016). 
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Figure 1 Folate profiling in the liver shown as percentage of total folate. SHR-1 congenic rats 
(solid bars) had significantly increased proportion of 5mTHF and decreased percentage of 
DHF, THF, and formyl-THF when compared to SHR (open bars). 5mTHF was the 
predominant form in both strains. * denotes P<0.05 
 
Figure 2 Distribution of differentially substituted folate species and the extent of 
glutamylation in the liver from SHR (open bars) and SHR-1 congenic rats (solid bars) 
expressed as percentage of individual folate species concentrations. Most of the hepatic 
5mTHF was in the form of monoglutamate and congenic rats had significantly higher 
percentage when compared to the SHR. On the other hand, 5mTHF penta- and/or 
hexaglutamates were significantly reduced in congenic rats versus the SHR. The same was 
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